Lung Cancer - Other

JANS Article

Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines for the Prevention of Cancer-Associated Venous Thromboembolism in Thoracic Surgery

March 23, 2023 | Cameron LindSilver Contributor

Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis, focusing on pharmacological and mechanical...

JANS Article

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

November 10, 2023 | Aristotle ProtopapasGold Commentor

A manuscript that wil certainly be discussed in lung MDT! The thought of a RCT in these earlier stages may be already in the mind of the sponsors… The authors...

JANS Article

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography

April 19, 2023 | Mark FergusonBronze Contributor

This study used lung cancer screening trial low dose CT scans to develop a model (Sybil) that predicts the likelihood of development of a lung cancer within the next year....

JANS Article

Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines for the Prevention of Cancer-Associated Venous Thromboembolism in Thoracic Surgery

March 23, 2023 | Cameron LindSilver Contributor

Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis,...

JANS Article

FDA Approves Drug Which Makes Lung Cancer Glow

January 6, 2023 | Cameron LindSilver Contributor

The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light....

JANS Article

Lung Nodule Analysis Model May Reduce Screening False Positives

May 23, 2018 | Mark FergusonBronze Contributor

Using eight computed tomography radiographic features in an automated algorithm, differentiating between benign and malignant status of indeterminate pulmonary nodules had an area under the curve of 0.939.

...
JANS Article

In Global News: Designs for Children’s Heart Surgery, Revisiting Tobacco Regulations, and Equally Good Lung Cancer Surgery Any Day of the Week

May 11, 2018 | Claire Vernon

Patient Care The Doodle Factory, an Egyptian brand that combines art and charity, has launched a new collection to fund heart surgeries for two children. Premium cigar makers in the...

JANS Article

In Global News: Quadruple Valve Surgery in the UAE, MitraClip Access in Japan, and Chewbacca Delivers Transplant News

March 23, 2018 | Claire Vernon

Patient Care A teen in Chicago, Illinois, USA, awaiting a heart transplant received the news that a heart was available from his pediatric cardiologist, who dressed up as Chewbacca from...

JANS Article

Extended Release of Perioperative Immunotherapy Prevents Tumor Recurrence and Eliminates Metastases

March 23, 2018 | Mark FergusonBronze Contributor

Surgery for cancer is known to suppress immune response and facilitate the development of metastases. In this study in mice, a scaffold designed to release agonists of innate immunity over...

JANS Article

Pleural Disease

February 23, 2018 | Aristotle ProtopapasGold Commentor

A comprehensive review of pleural diseases from the internists’ viewpoint. Relevant to surgeons in the sense of referrals for empyema, pleural effusions, and other traditional surgical problems that are now...

JANS Article

What Does It Take to Seal the Deal?

January 22, 2018 | Aristotle ProtopapasGold Commentor

A model analysis of a phase I surgical device trial. The readable editorial discusses the adoption of surgical innovation on the occasion of a harmonic sealing device for pulmonary resections,...

JANS Article

Lung Cancer: Blood-based Biomarker Predicts Immunotherapy Success

December 13, 2017 | Mark FergusonBronze Contributor

Liquid biopsies have long held promise for diagnosis, treatment selection, and surveillance of lung cancer patients. This articles summarizes results of two studies involving highly precise measurement of tumor mutational...

JANS Article

Assessment of Fluorodeoxyglucose F18–Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules

November 8, 2017 | Mark FergusonBronze Contributor

This multicenter retrospective study sought to assess the utility of PET in the diagnosis of pulmonary nodules. It emphasized the inclusion of patient cohorts from different geographic regions and who...

LOAD MORE
ADVERTISE ON CTSNET